Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05453825
Title A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors OncXerna Theraputics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Genesis Cancer Center RECRUITING Hot Springs Arkansas 71913 United States Details
Keck Medicine of USC RECRUITING Los Angeles California 90033 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Northside Hospital RECRUITING Atlanta Georgia 30322 United States Details
Hematology Oncology Clinic RECRUITING Baton Rouge Louisiana 70809 United States Details
New York University - Langone Health - Perlmutter Cancer Center RECRUITING New York New York 10016 United States Details
The Zangmeister Cancer Center RECRUITING Columbus Ohio 43219 United States Details
Tennessee Oncology RECRUITING Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field